Regenerative Medicine Market Size Worth USD 40.6 billion by 2027
The Global Regenerative Medicine Market in terms of revenue was estimated to be worth $12.2 Billion in 2022 and is poised to grow at a CAGR of 27.2% from 2022 to 2027. Market growth is driven by the availability of funding and rising investments in R&D, increasing clinical trials for stem cell and CAR-T cell therapies, and rising advancements in tissue-engineered products. However, the high treatment...
Regenerative Medicine Market Revenue Trends and Growth Drivers | MarketsandMarkets
The report “Regenerative Medicine Market by Product (Cell Therapy (Autologous, Allogenic), Gene Therapy, Tissue Engineering (Scaffold, Hydrogels), Application (Musculoskeletal, Oncology, Cardiovascular, Ophthalmology, Wound Care), Region – Global Forecast to 2027″, is projected to reach USD 40.6 billion by 2027 from USD 12.2 billion in 2022, at a CAGR of 27.2% during the forecast...
Cell Therapy Technologies Market to Receive Overwhelming Hike in Revenues by 2023
According to the new market research report “Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region – Global Forecast to 2023″, , published by MarketsandMarkets™, The global cell therapy technologies market is projected...
Synthetic Stem Cells Market by Application, Geographical Analysis – Global Forecast
The Global synthetic stem cell market size is expected to grow from $14 million in 2023 to $37 million by 2028, at a CAGR of 22.5%.
Currently, Artificial Stem Cells technology is co-developed and patented by North Carolina State University (NCSU) (US) and Zhengzhou University (China).
In line with the rising importance of stem cell, researcher Ke Cheng, an associate professor at North Carolina State...